Details of the Drug Formulaction

General Information of Drug Formulation (ID: F03076)

• Formulation Name: Cabergoline 0.5 mg tablet
• Company: Mylan Pharamceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Cabergoline	(DMQ4HIN)	Hyperprolactinaemia	5A60.1	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Leucine	(E00097)	6106	Antiadherent; Flavoring agent; lubricant
Magnesium stearate	(E00208)	11177	lubricant